Nature reviews. Cancer Journal Citation Rate 2026
1474-175X
eISSN 1474-1768
Springer Nature
GB
Q1 Quartile Top Tier
About Nature reviews. Cancer
Nature reviews. Cancer (NRC) is a peer-reviewed academic journal, published by Springer Nature in GB, catalogued under ISSN 1474-175X (e-ISSN 1474-1768). As of 2026, it has a 2024 2-Year Citation Rate (OpenAlex) of 64.80 (Q1 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model.
Nature reviews. Cancer Citation Rate 2026 — In Context
Nature reviews. Cancer has a 2024 2-Year Citation Rate (OpenAlex) of 64.80, placing it in the Q1 quartile. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.
Nature reviews. Cancer operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.
Researchers looking to publish in Nature reviews. Cancer should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Nature reviews. Cancer against similar journals in the field, use our journal comparison tool.
| ISSN (Print) | 1474-175X |
|---|---|
| ISSN (Online) | 1474-1768 |
| Publisher | Springer Nature |
| Country | United Kingdom |
| APC / Cost | Inquire with Publisher |
| h-index | 601 |
| Total Works | 4,706 |
| Total Citations | 1,147,567 |
| 2-yr Mean Citedness | 25.68 (OpenAlex) |
In-depth profile & metrics
Nature reviews. Cancer is published by Springer Nature and based in United Kingdom.
Editorially, Nature reviews. Cancer concentrates on Cancer Genomics and Diagnostics, Epigenetics and DNA Methylation and Cancer Cells and Metastasis.
Nature reviews. Cancer is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.
OpenAlex records 4,706 works that have together drawn 1,147,567 citations, giving the journal an h-index of 601; its citation rate has held broadly steady over the last 1 years, from 61.560 (2023) to 64.800 (2024); OpenAlex puts its two-year mean citedness at 25.68.
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about Nature reviews. Cancer
Live Indexing Status
Updated March 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
The impact factor has remained stable over the last 1 years (from 61.560 to 64.800), reflecting consistent citation performance.
Citation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2024 | 64.800 | 2-Year Mean Citedness (OpenAlex) |
| 2023 | 61.560 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Works Published per Year (2014–2025)
Annual publication volume sourced from OpenAlex. Current year omitted (partial data).
Publication & citation history by year
| Year | Works published | Citations received |
|---|---|---|
| 2025 | 115 | 2,308 |
| 2024 | 129 | 5,855 |
| 2023 | 112 | 8,927 |
| 2022 | 108 | 14,918 |
| 2021 | 111 | 24,439 |
| 2020 | 89 | 28,049 |
| 2019 | 135 | 30,007 |
| 2018 | 134 | 32,375 |
| 2017 | 124 | 38,899 |
| 2016 | 151 | 45,527 |
| 2015 | 182 | 37,189 |
| 2014 | 226 | 41,720 |
Journal at a Glance
Source: OpenAlex — refreshed daily.
Top Research Topics
The areas where Nature reviews. Cancer most frequently publishes, ranked by article volume. Click a topic to see the best journals for it.
Explore More Journals
Metadata
Last updated: Mar 15, 2026
Updated by: system
Get weekly updates
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.